Neonatal hypoglycemia, or low blood sugar in a newborn, happens when a baby’s blood glucose drops below safe levels in the first hours and days after birth. The most common causes are maternal diabetes, premature birth, and being born smaller than expected. While a mild, temporary dip in blood sugar is normal for all newborns in the first two to four hours of life, certain conditions prevent the baby from recovering and maintaining stable glucose on their own.
Why Blood Sugar Drops After Birth
Inside the womb, a baby receives a constant supply of glucose through the placenta. At birth, that supply stops abruptly. Every newborn experiences a natural dip in blood sugar during the first one to two hours of life, reaching its lowest point between two and four hours. By four to six hours, most healthy full-term babies stabilize their blood glucose at roughly 45 to 79 mg/dL through a combination of feeding, breaking down stored glycogen in the liver, and beginning to produce glucose on their own.
Problems arise when a baby either burns through glucose too quickly, doesn’t have enough stored energy to draw on, or can’t ramp up its own glucose production fast enough. The specific cause usually falls into one of several categories.
Maternal Diabetes
This is the single most common cause of temporary neonatal hypoglycemia. During pregnancy, glucose crosses freely from the mother’s blood into the placenta. When a mother has diabetes (whether gestational or pre-existing), her blood sugar runs higher than normal, and the baby’s pancreas responds by producing extra insulin and physically enlarging. At birth, the mother’s glucose supply cuts off, but the baby’s oversized pancreas keeps pumping out high levels of insulin. That excess insulin drives blood sugar dangerously low. It typically takes a few days for the baby’s pancreas to adjust, and the condition usually resolves on its own with feeding support or short-term glucose supplementation.
High maternal sugar intake late in pregnancy can produce a milder version of this same effect, even without a diabetes diagnosis.
Premature Birth
Babies born early face a double problem. First, the liver stockpiles most of its glycogen (stored sugar) during the final weeks of pregnancy, so preterm infants arrive with smaller reserves that get used up quickly. Second, and more importantly, the enzyme systems needed to manufacture new glucose are not fully developed in premature infants.
One key enzyme involved in converting other molecules into glucose has extremely low activity in preterm babies. Research has shown that even when preterm infants have plenty of raw materials circulating in their blood (like the amino acid alanine, which normally fuels glucose production), their livers simply cannot convert those materials into glucose efficiently. In one study of infants born at or before 32 weeks, giving alanine did not increase glucose production at all, confirming that the problem lies in the immaturity of the enzymatic machinery itself, not in a lack of building blocks.
Small or Growth-Restricted Babies
Babies born small for gestational age, often due to intrauterine growth restriction, face overlapping risks. They have decreased glycogen and fat stores, meaning less energy in reserve. They also tend to have inappropriate insulin release and impaired hormonal responses that would normally raise blood sugar when it drops. This combination makes them especially vulnerable in the hours after birth, even if they were born at full term.
Birth Stress and Oxygen Deprivation
A difficult delivery involving oxygen deprivation (perinatal asphyxia) rapidly depletes a newborn’s glucose. When blood flow and oxygen to the brain are compromised, the body shifts to a less efficient form of energy production that burns through glucose much faster. At the same time, reduced blood flow limits the delivery of fresh glucose to brain cells. The brain is extremely glucose-hungry under normal circumstances, so this combination can drive blood sugar levels down quickly and cause compounding damage.
Congenital Hyperinsulinism
While most cases of neonatal hypoglycemia are temporary, some babies have a genetic condition that causes their pancreas to release too much insulin on an ongoing basis. Congenital hyperinsulinism is the most common cause of persistent, severe low blood sugar in infants. Mutations in at least nine genes have been identified. The most frequently affected gene, ABCC8, accounts for about 40% of cases. Mutations in KCNJ11 are the next most common. In roughly half of all affected infants, no specific genetic cause has been identified yet.
Unlike the temporary hyperinsulinism caused by maternal diabetes, congenital hyperinsulinism does not resolve on its own within days. These babies have frequent, recurrent episodes of hypoglycemia that require ongoing medical management and sometimes surgery.
Metabolic Disorders That Block Alternative Fuels
Normally, when glucose runs low, the body can switch to burning fat for energy. Certain inherited metabolic conditions prevent infants from doing this. Fatty acid oxidation disorders disrupt the body’s ability to break down fat in the mitochondria (the energy-producing structures inside cells). During fasting or illness, when the body needs to rely on fat stores, these infants can’t access that energy source. The result is a characteristic pattern: low blood sugar without the expected rise in ketones (the byproducts of fat burning).
One of the more well-known examples, medium-chain acyl-CoA dehydrogenase deficiency, often first appears in infancy during a period of poor feeding or illness. The baby becomes lethargic, dehydrated, and develops dangerously low blood sugar. These conditions are now screened for in most newborn screening panels, which allows early identification and dietary management before a crisis occurs.
Other Contributing Factors
Several additional conditions increase the risk:
- Large for gestational age babies (over about 8 lbs 13 oz) may overproduce insulin similarly to infants of diabetic mothers, even when the mother has no diagnosed diabetes.
- Cold stress and hypothermia force a newborn to burn more glucose to maintain body temperature.
- Infection or sepsis increases the body’s metabolic demands while simultaneously impairing glucose regulation.
- Hormonal deficiencies involving growth hormone or cortisol can prevent the normal counter-regulatory response that raises blood sugar.
How It Shows Up in a Newborn
Many babies with low blood sugar show no obvious symptoms, which is why at-risk infants are screened routinely. When symptoms do appear, the most common signs are jitteriness or tremors, poor feeding, lethargy or floppiness, and an unusually weak or high-pitched cry. More concerning signs include pauses in breathing, a bluish skin color, sweating, eye rolling, and seizures. Symptoms can appear as early as the first hour of life, though timing depends on the underlying cause.
The distinction between transient and persistent hypoglycemia matters. Current guidelines suggest that babies unable to maintain blood sugar above 50 mg/dL in the first 48 hours, or above 60 mg/dL after that, need further evaluation to rule out an ongoing condition. Most cases are transient, resolving with early and frequent feeding. Persistent cases point toward genetic, hormonal, or metabolic causes that require specialized workup.
Why Timely Treatment Matters
Brief, mild dips in blood sugar are unlikely to cause lasting harm. Prolonged or symptomatic hypoglycemia is a different story. The connection between severe, sustained low blood sugar and brain injury in newborns is well established. A glucose level of 47 mg/dL became a widely used treatment threshold after research linked levels below that point to altered brain electrical activity and increased rates of developmental delay. The developing brain depends almost entirely on glucose for fuel, making newborns particularly vulnerable to supply interruptions during a period of rapid neural growth.